Background Dural arteriovenous fistulas (DAVFs) in the anterior cranial fossa constitute
approximately 1%–1.5% of intracranial vascular malformations. Depending on the drainage …

BACKGROUND Onyx is important embolic material in the endovascular treatment of
intracranial dural arteriovenous fistula (DAVF). However, its impact on DAVF occlusion rates …

Anterior cranial fossa (ACF) dural arteriovenous fistulae (DAVFs) are rare, and a systematic
review of the literature is lacking. Such a review is necessary, however, so a systematic …

Background Precise delivery of liquid embolic agents (LEAs) remains a challenge in the
endovascular treatment of dural arteriovenous fistulae (dAVFs) and cerebral arteriovenous …

OBJECTIVE Anterior cranial fossa dural arteriovenous fistulas (DAVFs) have been almost
exclusively considered as surgical lesions. However, new advances in endovascular …

Background Anterior cranial fossa dural arteriovenous fistulas (ACF-dAVFs) are aggressive
vascular lesions. The pattern of venous drainage is the most important determinant of …

Although microsurgery is an established treatment modality for intracranial dural
arteriovenous fistula (dAVF), data regarding the perioperative complication rate, cure rate …

Background Anterior cranial fossa dural arterio-venous fistulas (DAVFs) represent 6% of all
intracranial DAVFs; characteristically they show an aggressive behaviour with high risk of …

Purpose Dural arteriovenous fistulas (dAVF) account for approximately 10–15% of all
intracranial arteriovenous abnormalities. dAVFs carry a significant risk of mortality …

Objective To retrospectively review the outcome of patients with dural arteriovenous fistula of
the anterior cranial fossa (afDAVF) treated by transarterial embolization. Material and …